Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Climb Bio, Inc. - Common Stock (NQ: CLYM )

2.300 +0.050 (+2.22%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 308,019
Open 2.240
Bid (Size) 2.130 (1)
Ask (Size) 2.400 (1)
Prev. Close 2.250
Today's Range 2.180 - 2.355
52wk Range 1.800 - 5.860
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Climb Bio to be Added to the Nasdaq Biotechnology Index
From Climb Bio, Inc.
Via GlobeNewswire
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights
From Climb Bio, Inc.
Via GlobeNewswire

Performance

YTD
+11.11%
+11.11%
1 Month
-23.84%
-23.84%
3 Month
-56.27%
-56.27%
6 Month
-54.90%
-54.90%
1 Year
-54.90%
-54.90%

More News

Read More
Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
From Climb Bio, Inc.
Via GlobeNewswire
Climb Bio to Present at Upcoming Investor Conferences
From Climb Bio, Inc.
Via GlobeNewswire
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event
From Climb Bio, Inc.
Via GlobeNewswire
Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024
From Climb Bio, Inc.
Via GlobeNewswire
Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19
From Climb Bio, Inc.
Via GlobeNewswire
Climb Bio to Host Virtual Investor Event on October 15, 2024
From Climb Bio, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.